PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis.
Yamaguchi J, Isnard P, Robil N, de la Grange P, Hoguin C, Schmitt A, Hummel A, Megret J, Goudin N, Luka M, Ménager MM, Masson C, Zarhrate M, Bôle-Feysot C, Janiszewska M, Polyak K, Dairou J, Baldassari S, Baulac S, Broissand C, Legendre C, Terzi F, Canaud G.
J Clin Invest. 2024 Jun 6;134(15):e176402. doi: 10.1172/JCI176402.
PMID:38842935
Bruceine A protects nuclear receptor 4A1 from ubiquitin-degradation to alleviate mesangial proliferative glomerulonephritis.
Hu H, Li R, He K, Wu L, Li R, Lu J, Tian R, Zhang C, He J, Chen Y, Lai R, Zhang J, Wu J, Zheng Y, He J, Liu L, Chen X, Pan H.
Signal Transduct Target Ther. 2025 Dec 5;10(1):397. doi: 10.1038/s41392-025-02495-2.
Proliferative Glomerulonephritis With Hidden Monotypic IgG3kappa Deposits: A Case Report.
Kudose S, Batal I, Lucia J, Patel P, Soni RK, Markowitz GS, D'Agati VD, Stokes MB.
Am J Kidney Dis. 2023 Jan;81(1):114-117. doi: 10.1053/j.ajkd.2022.05.018. Epub 2022 Aug 2.
PMID:35931341
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A, Kawanishi K, Horita S, Koike J, Honda K, Ochi A, Komoda M, Tanaka Y, Unagami K, Okumi M, Shimizu T, Ishida H, Tanabe K, Nagashima Y, Nitta K.